Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF.
- DOI
- 10.1080/14760584.2026.2694387
- Published
- 2026 Dec
- Container
- Expert review of vaccines
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14760584.2026.2694387,
title = {Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF.},
author = {Ishiwada N and Wang X and Arashiro T and Reygrobellet C and Yarnoff B and Musci R and Ghemmouri M},
year = {2026},
journal = {Expert review of vaccines},
doi = {10.1080/14760584.2026.2694387},
url = {https://doi.org/10.1080/14760584.2026.2694387}
}RIS
TY - JOUR TI - Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF. AU - Ishiwada N AU - Wang X AU - Arashiro T AU - Reygrobellet C AU - Yarnoff B AU - Musci R AU - Ghemmouri M PY - 2026 JO - Expert review of vaccines DO - 10.1080/14760584.2026.2694387 UR - https://doi.org/10.1080/14760584.2026.2694387 ER -
APA
N, I., X, W., T, A., C, R., B, Y., R, M., & M, G. (2026). Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF.. Expert review of vaccines. https://doi.org/10.1080/14760584.2026.2694387
Source records
- pubmed · retrieved 2026-09-26T20:00:33.258Z